Harris S

ORCID: 0000-0003-2306-7921 · 7 papers in corpus
2026
Birth defects research ·doi:10.1002/bdr2.70011

BackgroundAdverse birth outcomes are important public health measures and account for a substantial public health burden. There is considerable diversity of these health endpoints, as well as in the many factors suspected or recognized to i…

2025
Journal of immunotoxicology ·doi:10.1080/1547691x.2025.2522041

Trichloroethylene (TCE) is a volatile synthetic chemical used in various industrial processes like metal degreasing. Large amounts of TCE have been released into the environment. Exposure to TCE can occur through routes, such as inhalation …

other 2021
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes ·doi:10.1177/0846537121998961

Historically thoracic MRI has been limited by the lower proton density of lung parenchyma, cardiac and respiratory motion artifacts and long acquisition times. Recent technological advancements in MR hardware systems and improvement in MR p…

2018
Emerging themes in epidemiology ·doi:10.1186/s12982-018-0081-y

BackgroundParticipation in epidemiologic studies has declined, raising concerns about selection bias. While estimates derived from epidemiologic studies have been shown to be robust under a wide range of scenarios, additional empiric study …

article 2017
Journal of autism and developmental disorders ·doi:10.1007/s10803-017-3283-1

Previous studies of associations between ASD and conception using assisted reproductive technology (ART) are inconsistent and few studies have examined associations with other infertility treatments or infertility disorders. We examined ass…

2015
Carcinogenesis ·doi:10.1093/carcin/bgv039

Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of ca…

article 1997
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513599709152533

The objective of this study was to compare the efficacy of nafarelin 200 micrograms (Group A), nafarelin 400 micrograms (Group B) and the combination of nafarelin 200 micrograms and norethisterone 1.2 mg (Group C) daily, in treating symptom…